Effectiveness of Beta Blockers against Hypertrophic Cardiomyopathy
DOI:
https://doi.org/10.53350/pjmhs22164358Keywords:
Hypertrophy cardiomyopathy, Intervention, Beta blockers, Left ventricleAbstract
Objective: To determine the efficacy of beta adrenergic blockers against hypertrophic cardiomyopathy.
Study Design: Retrospective study
Place and Duration of Study: Khyber Teaching Hospital Peshawar from 1st April 2021 to 30th September 2021.
Methodology: All the data was retrieved from the medical files of the patients who were registered as out/indoor patients at cardiology department. The sample size for this study was taken as 110 patients and age was between 5-76 years. Each patient complete information regarding age, gender, clinical history, comorbidity history, clinical symptoms, clinical assessment results, echo and ECG results was documented on a well-structured questionnaire. Patients were given beta blockers for two-year time and the effectiveness of various beta blockers was recorded.
Results: There were 57.27% males while 42.73% were females. Patients where increased left ventricle outflow-tract such as LVOT was observed the efficiency of beta blocker was significantly reduced. A value of LVOT ≥50mmHg was presented in patients of the later ages while LVOT <50mmHg was seen in young and pediatric cases.
Conclusion: Beta adrenergic blockers showed great effectiveness against hypertrophy cardiomyopathy.
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
